a year ago
COLL
AnalystsGregg GilbertGregg Gilbert's Stock Forecasts
AnalystsGregg Gilbert
Analyst Ranking
Top 13%
#627 out of 4875 analysts
Average Return
+16.71%
Win Rate
61%19 out of 31
Risk vs Reward
Poor
Good
Gregg Gilbert's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Impax Laboratories IncIPXL | +105.32% | $9.40 | $19.30 | 2017-03-08 - 2018-03-08 | Strong Buy |
Endo International PLCENDPQ | +99.37% | $7.94 | $15.83 | 2017-08-09 - 2018-08-09 | Strong Buy |
Eli Lilly & CoLLY | +94.03% | $464.50 | $901.26 | 2023-06-27 - 2024-06-26 | Strong Buy |
Eli Lilly & CoLLY | +84.87% | $463.82 | $857.47 | 2023-07-20 - 2024-07-19 | Strong Buy |
Novocure LtdNVCR | +47.30% | $25.00 | $36.83 | 2018-04-19 - 2018-07-26 | Strong Buy |
Gregg Gilbert Analyst Color
Get additional color on Gregg Gilbert's coverage of popular stocks
2 years ago
LLY
Gregg Gilbert's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dht Holdings IncDHT | 2 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Collegium Pharmaceutical IncCOLL | 1 | Strong Buy | $37.00 | N/A | Maintains | a year ago |
Bristol Myers Squibb CoBMY | 4 | Strong Buy | $84.00 | N/A | Reiterates | 2 years ago |
Eli Lilly & CoLLY | 6 | Strong Buy | $525.00 | N/A | Maintains | 2 years ago |
Evolus IncEOLS | 2 | Strong Buy | $13.00 | N/A | Maintains | 3 years ago |
Novocure LtdNVCR | 8 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Antares Pharma IncATRS | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 4 years ago |
Merck & Co IncMRK | 2 | Strong Buy | $93.00 | N/A | Maintains | 4 years ago |
Arcutis Biotherapeutics IncARQT | 1 | Strong Buy | $48.00 | N/A | Maintains | 4 years ago |
Allergan PLCAGN | 2 | Hold | $193.00 | N/A | Downgrades | 5 years ago |
Coherus Biosciences IncCHRS | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Pfenex IncPFNX | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 5 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 5 years ago |
Perrigo Co PLCPRGO | 2 | Hold | $78.00 | N/A | Downgrades | 7 years ago |
Zoetis IncZTS | 4 | Hold | $78.00 | N/A | Maintains | 7 years ago |
Teva Pharmaceutical Industries LtdTEVA | 2 | Hold | $18.00 | N/A | Maintains | 7 years ago |
Ligand Pharmaceuticals IncLGND | 3 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Teligent IncTLGT | 2 | Hold | $8.00 | N/A | Maintains | 8 years ago |
Lannett Co IncLCINQ | 2 | Hold | $76.00 | N/A | Maintains | 8 years ago |
Endo International PLCENDPQ | 1 | Strong Buy | $13.00 | N/A | Maintains | 8 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $175.00 | N/A | Maintains | 8 years ago |
Impax Laboratories IncIPXL | 2 | Strong Buy | $21.00 | N/A | Maintains | 8 years ago |
Abbvie IncABBV | 1 | Hold | $66.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.